TELO
NASDAQ · Pharmaceuticals
Telomir Pharmaceuticals Inc
$1.28
+0.00 (+0.00%)
Open$1.28
Previous Close$1.28
Day High$1.29
Day Low$1.26
52W High$4.81
52W Low$1.05
Volume—
Avg Volume76.8K
Market Cap45.38M
P/E Ratio—
EPS$-0.37
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.55M | 10.11M | 8.56M |
| Net Income | 1.76M | 2.03M | 1.53M |
| Profit Margin | 18.4% | 20.1% | 17.9% |
| EBITDA | 2.43M | 2.63M | 2.21M |
| Free Cash Flow | 1.02M | 1.59M | 1.30M |
| Rev Growth | -2.0% | +7.8% | +19.7% |
| Debt/Equity | 0.60 | 0.70 | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |